{"id":126535,"date":"2014-04-24T12:49:49","date_gmt":"2014-04-24T16:49:49","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/novel-therapeutic-agent-for-tamiflu-resistant-ph1n1-influenza-virus-discovered.php"},"modified":"2014-04-24T12:49:49","modified_gmt":"2014-04-24T16:49:49","slug":"novel-therapeutic-agent-for-tamiflu-resistant-ph1n1-influenza-virus-discovered","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/novel-therapeutic-agent-for-tamiflu-resistant-ph1n1-influenza-virus-discovered.php","title":{"rendered":"Novel therapeutic agent for Tamiflu-resistant pH1N1 influenza virus discovered"},"content":{"rendered":"<p><p>    PUBLIC RELEASE DATE:  <\/p>\n<p>    24-Apr-2014  <\/p>\n<p>    Contact: Denis Kainov    <a href=\"mailto:denis.kainov@fimm.fi\">denis.kainov@fimm.fi<\/a>    358-504-152-35460    University of    Helsinki<\/p>\n<p>    In 2009 the influenza pH1N1 virus caused the first flu pandemic    in the 21st century. The virus reached Finland in May 2009 and    killed more than 50 people in the country. Since 2011 the pH1N1    virus infects Finns mainly during flu epidemics (winter\/spring    seasons).  <\/p>\n<p>    Infections with influenza pH1N1 virus vary from asymptomatic to    serious complicated illnesses. World Health Organization has    recommended Tamiflu for treatment of patients with severe or    progressive illness. The disadvantage of this drug is that it    targets viral proteins which mutate quickly and the virus    develops resistance to it.  <\/p>\n<p>    The Medical Systems Virology group at FIMM, together with    collaborators has recently sequenced genomes of 135 pH1N1    influenza strains isolated from Finnish patients in 2009-2013    and found one Tamiflu-resistant strain from the 2012-2013    epidemic season. The study was published in the Genome    Announcements journal and is now available online.  <\/p>\n<p>    This finding suggests that there could be more resistant    strains in upcoming seasons. Therefore, there is a need for the    development of new antiviral agents against pH1N1, says Dr.    Triin Lakspere.  <\/p>\n<p>    In another study published this week the group investigated    influenza pH1N1 virus-host cell interaction in detail and found    that certain host function could be temporally inhibited with    small molecule MK2206 to block influenza infection in cell    culture.  <\/p>\n<p>    Importantly, the virus was unable to acquire resistance to    host-directed MK2206 in contrast to virus-directed Tamiflu.    This small molecule is in clinical trials against cancer and    has high specificity and good pharmacological properties, which    could warrant its further development as antiviral drug for    treatment of pH1N1 virus infection, Dr. Oxana Denisova says.  <\/p>\n<p>    ###  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Continued here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2014-04\/uoh-nta042414.php\/RK=0\/RS=ozAUbceDPITVI4bUaOrRZ1mEeqE-\" title=\"Novel therapeutic agent for Tamiflu-resistant pH1N1 influenza virus discovered\">Novel therapeutic agent for Tamiflu-resistant pH1N1 influenza virus discovered<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PUBLIC RELEASE DATE: 24-Apr-2014 Contact: Denis Kainov <a href=\"mailto:denis.kainov@fimm.fi\">denis.kainov@fimm.fi<\/a> 358-504-152-35460 University of Helsinki In 2009 the influenza pH1N1 virus caused the first flu pandemic in the 21st century. The virus reached Finland in May 2009 and killed more than 50 people in the country. Since 2011 the pH1N1 virus infects Finns mainly during flu epidemics (winter\/spring seasons) <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/novel-therapeutic-agent-for-tamiflu-resistant-ph1n1-influenza-virus-discovered.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[26],"tags":[],"class_list":["post-126535","post","type-post","status-publish","format-standard","hentry","category-molecular-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/126535"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=126535"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/126535\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=126535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=126535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=126535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}